PCK2 and type 2 diabetes mellitus: And CA could strongly improve impaired glucose, hyperlipidemia and insulin resistance in T2D models, which were relied on declining the expression of PEPCK and other genes involved in carbon metabolism, T2D related oxidative stress and inflammation.